Congenital ID | TNDM | upd(6)mat | SRS | BWS | TS14 | KOS14 | PWS | AS | Precocious puberty | upd(16)mat | PHP | upd(20)mat | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reference | [18] | Weba | [83] | [33] | [43] | [84] | [52] | [85] | [61] | Weba | [86] | [70] | |
number of patients | 155 | 13 | 20 | 44 | 403 | 51 | 34 | 90 | Â | Â | 61 | 63 | 15 |
ID specific chromosome | 6 | 6 | 7 | 11 | 11 | 14 | 14 | 15 | 15 | 15 | 16 | 20 | 20 |
clinical overlap with | BWS | SRS | upd(6)mat, TS14, upd(16)mat, upd(20)mat | TNDM, KOS14 | SRS, PWS | BWS | TS14 | AS infant | Â | SRS, upd(6)mat, upd(20)mat | Â | SRS, upd(6)mat, upd(16)mat | |
 | Major clinical and overlapping findings | ||||||||||||
IUGR | Yes | 53.8Â % (7/13) | 70Â % | 82Â % | Â | 87Â % | 1 | Rare | No | Â | 77Â % (47/61) | Â | 100Â % |
prenatal overgrowth | Â | Â | Â | Â | Yes | Â | 58.8Â % (20/34) | Â | No | Â | Â | Yes | Â |
placenta | Â | Â | Abnormality: 8Â % | Abnormality: 35Â % | Placentomegaly | Â | Placentomegaly | Â | No | Â | Â | Â | Â |
polyhydramion | Â | Â | Â | Â | Reported | Â | 97Â % (33/34) | Â | No | Â | Â | Â | Â |
PNGR | Yes | 33.3Â % (2/6) | 65Â % | 57Â % | Â | 79Â % | 36.6Â % (11/30) | 63Â % | No | Â | 2Â % (1/49) | Â | 100Â % |
overgrowth | Â | Â | Â | Â | Yes | Â | (6.7Â % (2/30) | Â | No | Â | Â | Â | Â |
organomegaly | Â | Â | Â | Â | 43.8Â % (153/349) | Â | Â | Â | No | Â | Â | Â | Â |
Asymmetry | Â | Â | 30Â % | 68Â % | 33.3Â % (126/378 | 4Â % | Â | Â | No | Â | Â | Â | Â |
macroglossia | 44Â % (54/123) | Â | Â | Â | 94Â % (379/403) | Â | Â | Â | No | Â | Â | 7Â % (3/35) | Â |
relative macrocephaly | Â | Â | 90Â % | 70Â % | Â | 56Â % | Â | Â | No | Â | Â | Â | 1 case |
relative microcephaly | Â | 1 case | Â | Â | Â | Â | Â | Â | >80Â % | Â | Â | Â | Â |
hypotonia |  |  | 45 % (n = 143) [87] |  | 93 % |  | 88 % | <80 % |  |  |  | 1 case | |
abdominal wall defects | 21Â % (24/114) | 1 case | Rare | Â | 62.3Â % (250/401) | Â | Omphalocele: 32.3Â % (11(34) | Â | No | Â | 1 case | Â | Â |
 | Exomphalos: 56.8 % (142/250) |  | diastasis recti: 67.6 % (23/34) | ||||||||||
glycemic disorder | TNDM: 100Â % | Â | Hypoglycemia: 24Â % | Hypoglycemia: 19Â %; diabetes type 2 reported in later life | Hypoglycemia: 43.4Â % (162/373) | Hypoglycemia diabetes type 2 reported in later life | Â | Diabetes type 2: 25Â % | no | Â | Â | Â | Â |
precocious puberty | Â | Â | Frequent | Frequent | Reported | 86Â % | Â | 4Â % [88] | No | 100Â % | Â | Â | Â |
mental retardation | Â | Â | Global delay: 65Â % | Global delay: 20Â % | Â | 39Â % | Â | 100Â % | 100Â % | Â | Â | 3Â % | Â |
speech delay | Â | Â | 50Â % | 39Â % | Â | Â | Â | Â | No speech | Â | Â | Â | Â |
motor delay | Â | Â | 50Â % (7/14) | 76Â % (26/34) | Â | Â | Â | Â | 100Â % | Â | Â | Â | Â |
learning difficulties | Â | Â | Â | Â | Â | Â | Â | Â | 100Â % | Â | Â | 33Â % | Â |
behaviour | Â | Â | 20Â % | 9Â % | Â | Â | Â | 70-90Â % | 100Â % | Â | Â | 9Â % | Â |
feeding difficulties | Â | Â | 90Â % | 84Â % | Reported | 43Â % | Â | 78Â % | >80Â % | Â | Â | Â | 7 cases |
seizures | Â | 1 case | Â | Â | Â | Â | Â | Â | >80Â % | Â | Â | Â | 1 case |
excessive sweating | Â | Â | 75Â % | 64Â % | Â | Â | Â | Â | Increased sensitivity to heat | Â | Â | Â | Â |
scoliosis | Â | Â | 5Â % | 9Â % | Â | 23Â % | Â | 40-80Â % [88] | <80Â % | Â | Â | Â | 1 case |
adipositas | Â | Â | Â | Reported in later life [21] | Â | yes | Â | 67Â % | <80Â % | Â | Â | Â | Â |
dysmorphic/typical facial gestalt | 18Â % (21/114) | Â | Triangular face | Â | Â | 100Â % | Â | >80Â % | Â | 14.2Â % (6/49) | Â | Mild | |
clinodactyly/finger abnormalities | 8Â % (9/116) | Â | 45Â % | 75Â % | Â | Â | Â | Â | Â | Â | Â | Â | 5 cases |
ear abnormalities | Â | Â | Low set posterior | Low set posterior | 61.8Â % (230/372) | Â | Â | Â | Â | Â | Â | Â | Â |
otitis media | Â | Â | 20Â % | 14Â % | Â | 17.6Â % (9/51) | Â | Â | Â | Â | Â | Â | Â |
hepatoblastoma | Â | Â | Â | Â | Reported | Â | Reported | Â | Â | Â | Â | Â | Â |
cardiac anomalities | 9Â % (10/114) | Â | Â | 9Â % | 5-10Â % [39] | Â | Â | Â | Â | Â | Â | Â | Â |